Sex-related differences in the use and adverse effects of angiotensin-converting enzyme inhibitors in heart failure: the study of patients intolerant of converting enzyme inhibitors registry.
暂无分享,去创建一个
M. Pfeffer | J. McMurray | K. Swedberg | C. Granger | E. Michelson | M. Petrie | L. Stevenson | B. Bart | G. Tudor | M. Shah | R. Califf
[1] M. Pfeffer,et al. Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors. , 2000, American heart journal.
[2] C B Granger,et al. Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry. , 1999, European heart journal.
[3] D. Blumenthal,et al. National patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure. , 1997, Archives of internal medicine.
[4] H. Krause-Steinrauf,et al. Where are all the women with heart failure? , 1997, Journal of the American College of Cardiology.
[5] J. Feinglass,et al. Heart failure between 1986 and 1994: temporal trends in drug-prescribing practices, hospital readmissions, and survival at an academic medical center. , 1997, American heart journal.
[6] M. Rich,et al. CONGESTIVE HEART FAILURE IN OLDER ADULTS * : Epidemiology, Pathophysiology, and Etiology of Congestive Heart Failure in Older Adults , 1997, Journal of the American Geriatrics Society.
[7] D E Grobbee,et al. The epidemiology of heart failure. , 1997, European heart journal.
[8] M B Weiss,et al. Adverse effects of enalapril in the Studies of Left Ventricular Dysfunction (SOLVD). SOLVD Investigators. , 1996, American heart journal.
[9] S. Yusuf,et al. Tolerability of enalapril initiation by patients with left ventricular dysfunction: results of the medication challenge phase of the Studies of Left Ventricular Dysfunction. , 1994, American heart journal.
[10] R. Cody. Clinical trials of diuretic therapy in heart failure: research directions and clinical considerations. , 1993, Journal of the American College of Cardiology.
[11] D. Levy,et al. The epidemiology of heart failure: the Framingham Study. , 1993, Journal of the American College of Cardiology.
[12] W. Gaasch,et al. Clinical characteristics of patients in studies of left ventricular dysfunction (SOLVD). , 1992, The American journal of cardiology.
[13] E. J. Brown,et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.
[14] S. Yusuf,et al. Studies of Left Ventricular Dysfunction (SOLVD) Registry: rationale, design, methods and description of baseline characteristics. , 1992, The American journal of cardiology.
[15] Salim Yusuf,et al. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.
[16] Cockcroft Dw,et al. Prediction of Creatinine Clearance from Serum Creatinine , 1976 .